Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice
Open Access
- 1 August 2010
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 78 (3), 279-286
- https://doi.org/10.1038/ki.2010.132
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phaseMolecular Immunology, 2009
- FBXW7 Targets mTOR for Degradation and Cooperates with PTEN in Tumor SuppressionScience, 2008
- Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancerNature Reviews Cancer, 2008
- FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiationNature Reviews Cancer, 2008
- Translational Mini-Review Series on Complement Factor H: Renal diseases associated with complement factor H: novel insights from humans and animalsClinical and Experimental Immunology, 2008
- Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibitionProceedings of the National Academy of Sciences, 2007
- SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IκB-α/NF-κBThe Journal of cell biology, 2007
- Drug discovery in the ubiquitin–proteasome systemNature Reviews Drug Discovery, 2006
- Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient miceProceedings of the National Academy of Sciences, 2006
- Function and regulation of cullin–RING ubiquitin ligasesNature Reviews Molecular Cell Biology, 2005